FIELD: medicine, pharmaceutics.
SUBSTANCE: there are presented a method for preventing, suppressing or treating a depressive disorder associated with multiple sclerosis, involving administering a therapeutically effective amount of a S1P receptor modulator specified in 2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol in the free form or in the form of a pharmaceutically acceptable salt, and FTY720-phosphate and using the above compounds for preparing a drug preparation for the same application.
EFFECT: patient's health improvement in recurrent multiple sclerosis, either relapsing-remitting, or secondary-progressive has been shown.
5 cl, 6 dwg
